Tripathi et al.
SCHEME 1
ridyl, oxazoline, oxazine, and carbonyl groups. There are
very few studies involving the coordinating hydroxy,
ether, and halogen groups. The notable exception is the
pioneering work of Tomoda and co-workers, where in-
tramolecular Se‚‚‚OH, Se‚‚‚OR, and Se‚‚‚halogen interac-
tions have been systematically investigated mainly by
multinuclear NMR and theoretical studies (1-3).7 How-
ever, there are no reports on structural characterization
of E‚‚‚OH interactions in the solid state.
The organochalcogens with an o-hydroxy function (or
hydroxy group present in close proximity) have attracted
attention due to their relevance (i) in organic synthesis,8
(ii) in biochemistry,9 (iii) as intermediates in the catalytic
cycle of seleninate esters,10 (iv) as precursors for GPx
mimics,10 and (v) as hydroxy-containing mimics have
better solubility in water for conducting the bioassay.11
Wirth and co-workers8 have demonstrated the use of 4
and related diselenides in stereoselective selenenylation
reactions. An intramolecular Se‚‚‚O interaction is neces-
sary for high diastereoselectivity. The diselenides with
a free hydroxy group give the highest diastereoselectivity.
Interestingly, the single-crystal structure of 4b does not
show Se‚‚‚OH interaction. Instead, it shows Se‚‚‚OMe
interaction.
The discovery of selenium as selenocysteine in the
active site of the selenoenzyme glutathione peroxidase
(GPx) has led to a growing interest in the biochemistry
of selenium.12 The selenoenzyme functions as an anti-
oxidant and catalyzes the reduction of harmful peroxides
by glutathione and protects the lipid membranes against
oxidative damage.13 The enzyme’s catalytic site includes
a selenocysteine residue in which the selenium undergoes
a redox cycle involving the selenol (Enz-SeH) as the active
form that reduces hydroperoxides and organic peroxides.
The selenol is oxidized to the selenenic acid (Enz-SeOH),
which reacts with reduced glutathione (GSH) to form the
selenenyl sulfide adduct (Enz-SeSG). A second glu-
tathione then regenerates the active form of the enzyme
by attacking the sulfide to form the oxidized glutathione
(GSSG) (Scheme 1).14
(2) (a) Wilson, S. R.; Zucker, P. A.; Huang, R.-R. C.; Spector, A. J.
Am. Chem. Soc. 1989, 111, 5936. (b) Spector, A.; Wilson, S. R.; Zucker,
P. A. U.S. Patent 5,321,138 (C1, 546-224; C07C37/02), 1994; Chem.
Abstr. 1994, 121, P256039r. (c) Engman, L.; Stern, D.; Cotgreave, I.
A.; Andersson, C. M. J. Am. Chem. Soc. 1992, 114, 9737. (d) Galet, V.;
Bernier, J.-L.; Henichart, J.-P.; Lesieur, D.; Abadie, C.; Rochette, L.;
Lindenbaum, A.; Chalas, J.; Faverie, J.-F. R.; Pfeiffer, B.; Renard, P.
J. Med. Chem. 1994, 37, 2903. (e) Iwaoka, M.; Tomoda, S. J. Am. Chem.
Soc. 1994, 116, 2557. (f) Mugesh, G.; Panda, A.; Singh, H. B.; Punekar,
N. S.; Butcher, R. J. Chem. Commun. 1998, 2227. (g) Mugesh, G.;
Panda, A.; Singh, H. B.; Punekar, N. S.; Butcher, R. J. J. Am. Chem.
Soc. 2001, 123, 839. (h) Mugesh, G.; du Mont, W.-W. Chem. Eur. J.
2001, 7, 1365.
(3) (a) Singh, A. K.; Sharma, S. Coord. Chem. Rev. 2000, 209, 49.
(b) Levason, W.; Orchard, S. D.; Reid, G. Coord. Chem. Rev. 2002, 225,
159. (c) Iwaoka, M.; Tomoda, S. J. Chem. Soc., Chem. Commun. 1992,
1165. (d) Fujita, K.; Iwaoka, M.; Tomoda, S. Chem. Lett. 1994, 923. (e)
Wirth, T. Tetrahedron Lett. 1995, 36, 7849. (f) Kaur, R.; Singh, H. B.;
Patel, R. P. J. Chem. Soc., Dalton Trans. 1996, 2719. (g) Fukuzawa,
S.; Takahashi, K.; Kato, H.; Yamazaki, H. J. Org. Chem. 1997, 62,
7711. (h) Wirth, T.; Hauptli, H.; Leuenberger, M. Tetrahedron: Asym-
metry 1998, 9, 547. (i) Uemura, S. Phosphorus, Sulfur Silicon Relat.
Elem. 1998, 136-138, 219. (j) Hiroi, K.; Suzuki, Y.; Abe, I. Tetrahedron:
Asymmetry 1999, 10, 1173. (k) Ehara, H.; Noguchi, M.; Sayama, S.;
Onami, T. J. Chem. Soc., Perkin Trans. 1 2002, 1429. (l) Braga, A. L.;
Paixao, M. W.; Ludtke, D. S.; Silveira, C. C.; Rodrigues, O. E. D. Org.
Lett. 2003, 5, 2635.
(4) (a) Bonasia, P. J.; Arnold, J. J. Organomet. Chem. 1993, 449,
147. (b) Cheng, Y.; Emge, T. J.; Brennan, G. Inorg. Chem. 1994, 33,
3711. (c) Cheng, Y.; Emge, T. J.; Brennan, G. Inorg. Chem. 1996, 35,
3342. (d) Cheng, Y.; Emge, T. J.; Brennan, G. Inorg. Chem. 1996, 35,
7339. (e) Mugesh, G.; Singh, H. B.; Butcher, R. J. Inorg. Chem. 1998,
37, 2663. (f) Mugesh, G.; Singh, H. B.; Butcher, R. J. J. Organomet.
Chem. 1999, 577, 243. (g) Kandasamy, K.; Singh, H. B.; Wolmer-
shau¨ser, G. Inorg. Chim. Acta 2005, 358, 207.
(5) (a) Mugesh, G.; Singh, H. B. Acc. Chem. Res. 2002, 35, 226. (b)
Mugesh, G.; Panda, A.; Kumar, S.; Apte, S. D.; Singh, H. B.; Butcher,
R. J. Organometallics 2002, 21, 884. (c) Kandasamy, K.; Kumar, S.;
Singh, H. B.; Wolmersha¨user, G. Organometallics 2003, 22, 5069. (d)
Apte, S. D.; Zade, S. S.; Singh, H. B.; Butcher, R. J. Organometallics.
2003, 22, 5473. (e) Kumar, S.; Kandasamy, K.; Singh, H. B.; Wolm-
ersha¨user, G.; Butcher, R. J. Organometallics 2004, 23, 4199. (f) Zade,
S. S.; Singh, H. B.; Butcher, R. J. Angew. Chem., Int. Ed. 2004, 43,
4513. (g) Zade, S. S.; Panda, S.; Tripathi, S. K.; Singh, H. B.;
Wolmersha¨user, G. Eur. J. Org. Chem. 2004, 18, 3857. (h) Kumar, S.;
Kandasamy, K.; Singh, H. B.; Butcher, R. J. New. J. Chem. 2004, 28,
640. (i) Kandasamy, K.; Kumar, S.; Singh, H. B.; Butcher, R. J.;
Holman, K. T. Organometallics 2004, 5, 1014. (j) Zade, S. S.; Panda,
S.; Singh, H. B.; Sunoj, R. B.; Butcher, R. J. J. Org. Chem. 2005, 70,
3693.
Simple organoselenium compounds have been shown
to mimic the GPx activity in vitro. These include ebselen
(2-phenyl-1,2-benzoisoselenazol-3-(2H)-one 5),15 ebselen
analogues,16 benzoselenazolinones,17 selenamide and re-
lated derivatives,18 diaryl diselenides 6 and 7,2a,f,g,19
various tellurides and ditellurides,2c,5b,20 and the semi-
(8) (a) Wirth, T.; Fragale, G.; Chem. Eur. J. 1997, 3, 1894. (b)
Fragale, G.; Neuberger, M.; Wirth, T. Chem. Commun. 1998, 1867.
(9) Wirth, T. Molecules 1998, 3, 164.
(10) (a) Back, T. G.; Moussa, Z. J. Am. Chem. Soc. 2002, 124, 12104.
(b) Back, T. G.; Moussa, Z. J. Am. Chem. Soc. 2003, 125, 13455.
(11) Iwaoka, M.; Takahashi, T.; Tomoda, S. Heteroatom Chem. 2001,
12, 293.
(12) (a) Rotruck, J. T.; Pope, A. L.; Ganther, H. E.; Swanson, A. B.;
Hafeman, D. G. Science 1973, 179, 588. (b) Flohe¨, L.; Gunzler, W. A.;
Schock, H. H. FEBS Lett. 1973, 32, 132.
(6) (a) Goldstein, B. M.; Kennedy, S. D.; Hennen, W. J. J. Am. Chem.
Soc. 1990, 112, 8265. (b) Burling, F. T.; Goldstein, B. M. J. Am. Chem.
Soc. 1992, 114, 2313. (c) Barton, D. H. R.; Hall, M. B.; Lin, Z.; Parekh,
S. I.; Reibenspies, J. J. Am. Chem. Soc. 1993, 115, 5056. (d) Fujihara,
H.; Mima, H.; Furukawa, N. J. Am. Chem. Soc. 1995, 117, 10153. (e)
Furukawa, N.; Kobayashi, K.; Sato, S. J. Organomet. Chem. 2000, 611,
116 and references therein. (f) Nakanishi, W.; Hayashi, S.; Itoh, N.
Chem. Commun. 2003, 124 and references therein. (g) Klapo¨tke, T.
M.; Krumm, B.; Polborn, K. J. Am. Chem. Soc. 2004, 126, 710. (h)
Nakanishi, W.; Hayashi, S.; Itoh, N. J. Org. Chem. 2004, 69, 1676.
(7) (a) Komatsu, H.; Iwaoka, M.; Tomoda, S. Chem. Commun.1999,
2, 205. (b) Iwaoka, M.; Katsuda, T.; Tomoda, S.; Harada, J.; Ogawa,
K. Chem. Lett. 2002, 5, 518. (c) Iwaoka, M.; Takemoto, S.; Tomoda, S.
J. Am. Chem. Soc. 2002, 124, 0613. (d) Iwaoka, M.; Komatsu, H.;
Katsuda, T.; Tomoda, S. J. Am. Chem. Soc. 2004, 126, 5309. (e) Iwaoka,
M.; Takayuki, K.; Hiroto, K.; Tomoda, S. J. Org. Chem. 2005, 70, 321.
(13) (a) Mugesh, G.; du Mont, W. W.; Sies, H. Chem. Rev. 2001, 101,
2125. (b) Mugesh, G.; Singh, H. B. Chem. Soc. Rev. 2000, 29, 347. (c)
Selenium in Biology and Human Health; Burk, R. F., Ed.; Springer:
New York, 1994. (d) Flohe¨, L. Curr. Top. Cell Regul. 1985, 27, 473. (e)
Tappel, A. L. Curr. Top. Cell. Regul. 1984, 24, 87. (f) Epp, O.;
Ladenstein, R.; Wendel, A. Eur. J. Biochem. 1983, 133, 51. (g) Flohe¨,
L.; Loschen, G.; Gunzler, W. A.; Eichele, E. Hoppe-Seyler’s Z. Physiol.
Chem. 1972, 353, 987.
(14) Ganther, H. E. Chem. Scr. 1975, 8a, 79. (b) Ganther, H. E.;
Kraus, R. J. In Methods in Enzymology; Colowick, S. P., Kaplan, N.
O., Eds.; Academic Press: New York, 1984; Vol. 107, pp 593-602.
(15) (a) Mu¨ller; A.; Cadenas, E.; Graf, P.; Sies, H. Biochem. Phar-
macol. 1984, 33, 3235. (b) Wendel, A.; Fausel, M.; Safayhi, H.; Tiegs,
G.; Otter, R. Biochem. Pharmacol. 1984, 33, 3241. (c) Parnham, M. J.;
Kindt, S. Biochem. Pharmacol. 1984, 33, 3247. (d) Wendel, A. European
Patent 0-165-534, 1985.
9238 J. Org. Chem., Vol. 70, No. 23, 2005